Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

Hops and hop extracts are increasingly being investigated for their beneficial health effects.

• Hop extract itself is not acutely toxic (LD50 >2,000 mg per kg bw for most hop extracts; potentially 1,000 – 2,300 mg per kg bw for β-acid-enriched extracts).

• The bitter acids (α-, β- and iso-α-acids are thought to be metabolised principally by phase I, leading to oxygenated derivatives that are similar to oxygenated compounds found in aged hops and aged beer. Rabbit and human data have shown that iso-α-acids have a short half-life.

• Oxygenated derivatives, known as matured hop bitter acids, have themselves been trialled as therapeutic agents in a human trial, and were considered to be safe over the 12-week period.

• Taken together, these data suggest that further animal studies on hop toxicokinetics are not warranted. In view of the growing interest in hop-derived compounds as possible therapeutic substances, more information on safety and toxicology will emerge as new therapeutic target compounds are tested.

Key value for chemical safety assessment

Bioaccumulation potential:
no bioaccumulation potential
Absorption rate - oral (%):
80

Additional information